semaglutide patent india expiry in opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent Semaglutide patent expiry in India

Iepsen EW, Lundgren JR, Hartmann B, Pedersen O, Hansen T, Jorgensen NR, Jensen JE, Holst JJ, Madsbad S, Torekov SS

Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P

In the landscape of pharmaceuticals, Semaglutide , Ozempic , Wegovy, and Mounjaro are noteworthy contenders, each having a significant impact on the management of conditions such as obesity and type 2 diabetes

This article provides general scientific information regarding standard laboratory research contexts only, and does not constitute a validated experimental protocol, medical guidance, clinical guidance, veterinary guidance, or treatment advice.

In the meantime, Eli Lilly should remain the leader in weight loss thanks to Zepbound, and other highly promising pipeline candidates, such as retatrutide, whose recent phase 3 results have been compared to what we typically see in bariatric surgeries

GLP-1 medications arent without risksespecially when misused or taken without medical supervision